Long-term follow-up and outcome of 39 patients with chronic granulomatous disease

Journal of Pediatrics

Volumn 137, Issue 5, 2000, Pages 687-693

  Liese, Johannes ^a,b,c   Kloos, Sibylle ^a,b,c   Jendrossek, Verena ^a,b,c   Petropoulou, Theoni ^a,b,c   Wintergerst, Uwe ^a,b,c   Notheis, Gundula ^a,b,c   Gahr, Manfred ^a,b,c   Belohradsky, Bernd ^a,b,c  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY HOSPITAL CARL GUSTAV CARUS   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CYTOCHROME B558;

ANTIBIOTIC THERAPY; ARTICLE; ASPERGILLUS; CHILD; CHRONIC GRANULOMATOUS DISEASE; CLINICAL ARTICLE; DISEASE COURSE; FEMALE; FOLLOW UP; GINGIVITIS; HUMAN; LYMPHADENITIS; LYMPHADENOPATHY; MALE; MORTALITY; PNEUMONIA; PRIORITY JOURNAL; PROPHYLAXIS; SKIN ABSCESS; STAPHYLOCOCCUS; STOMATITIS; SURVIVAL RATE;

EID: 0033739697     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2000.109112     Document Type: Article

References (24)

1. Molecular basis of chronic granulomatous disease
2. Molecular basis of the autosomal recessive forms of chronic granulomatous disease
3. Chronic granulomatous disease in adults
4. Identification of the defective NADPH-oxidase component in chronic granulomatous disease: A study of 57 European families
5. Chronic granulomatous disease with partial deficiency of cytochrome b558 and incomplete respiratory burst: Variants of the X-linked, cytochrome b(558)-negatlve form of the disease
6. Trimethoprim-Sulfamethoxazole prophylaxis in the management of chronic granulomatous disease
7. Continuous therapy with sulfamethoxazole-trimethoprim in patients with chronic granulomatous disease
8. A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease
9. Interferon gamma for chronic granulomatous disease
10. Long-term itraconazole prophylaxis against Aspergillus infections in thirty-two patients with chronic granulomatous disease
11. Nitroblue-Tetrazolium test for the detection of chronic granulomatous disease-technical modification
12. Activity and activation of the granulocyte superoxide -generating system
13. Cytocrome b, flavlns and ubiquinone-50 in enucleated human neutrophils
14. 558 of human neutrophils: Immunocytochemical detection of the antigen in peripheral phagocytes of normal subjects, patients with chronic granulomatous disease and their carrier mothers
15. Improvement of superoxide production in monocytes from patients with chronic granulomatous disease by recombinant cytokines
16. Long-term treatment of patients with itraconazole for the prevention of Aspergillus infections in patients with chronic granulomatous disease
17. Prognosis of chronic granulomatous disease
18. Prevalence, genetics and clinical presentation of chronic granulomatous disease in Sweden
19. Incidence, severity, and prevention of infections in chronic granulomatous disease
20. The phagocyte system. Disorders of oxidative metabolism
21. Clinical features and current management of chronic granulomatous disease
22. Fungal infection in chronic granulomatous disease. The importance of the phagocyte in defense against fungi
23. Successful treatment with voriconazole of invasive aspergillosis in chronic granulomatous disease
24. Itraconazole resistance in Aspergillus fumigatus